Janux Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Janux Therapeutics, Inc. (JANX) had Common Stock, Capital Shares Reserved for Future Issuance of 23.68 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 23.68M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 23.90M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 20.75M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 21.01M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 23.68M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 23.90M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 20.75M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 21.01M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 21.84M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 21.97M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 18.53M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 18.87M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 19.04M shares 10-Q · filed 2024-08-07 |
| 2024-03-31 | 19.36M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 14.83M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 14.93M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 14.47M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 14.53M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 12.17M shares 10-K · filed 2025-02-27 |
| 2021-12-31 | 9.74M shares 10-K · filed 2023-03-10 |
| 2021-09-30 | 9.75M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 9.75M shares 10-Q · filed 2021-08-10 |
| 2020-12-31 | 10.08M shares 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |